Michael Fanucchi

Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002

Robert G. Maki, J. Kyle Wathen, Shreyaskumar Patel et al. · Journal of Clinical Oncology · 2007 · 733 citations

Medicine, Oncology, Pharmacology +17

Effects of Polyethylene Glycol–Conjugated Recombinant Human Megakaryocyte Growth and Development Factor on Platelet Counts after Chemotherapy for Lung Cancer

Michael Fanucchi, John A. Glaspy, Jeffrey Crawford et al. · New England Journal of Medicine · 1997 · 294 citations · Full text

Medicine, Oncology, Pharmacology +8

Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitors

Jibran Ahmed, Arun Kumar, Kaushal Parikh et al. · OncoImmunology · 2018 · 173 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Randomized Phase II Study of Bortezomib Alone and Bortezomib in Combination With Docetaxel in Previously Treated Advanced Non–Small-Cell Lung Cancer

Michael Fanucchi, Frank V. Fossella, Robert J. Belt et al. · Journal of Clinical Oncology · 2006 · 156 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Phase I Combination Study of Trabectedin and Doxorubicin in Patients with Soft-Tissue Sarcoma

Jean‐Yves Blay, Margaret von Mehren, Brian L. Samuels et al. · Clinical Cancer Research · 2008 · 84 citations · Full text

Pharmacy, Oncology, Pharmacology +15